The choice of biological drug for the treatment of rheumatoid arthritis is a highly significant one and should be informed by a clear understanding of the patient’s disease profile.

Biologic therapy has revolutionised the treatment armamentarium of inflammatory joint diseases and a host of other autoimmune diseases.

Please sign in to read more